Insemination and no sex

Porn Videos

Artificial insemination (AI) is the deliberate introduction of sperm into a female's cervix or uterine cavity for the purpose of achieving a pregnancy through in vivo fertilization by means other than sexual intercourse. resulting from artificial insemination is no different from a pregnancy achieved by sexual intercourse. In all. ceeding 10 million for IUI, no further improvement in conception rates was but intercourse on the day of hCG administration might cause con-. During IUI treatment, there are certain points in time when intercourse is not recommended. The most discouraged time is the day following the.

Here are three ways you can conceive without sexual intercourse. Artificial insemination is when semen is collected and then transferred into. Artificial insemination (AI) is the deliberate introduction of sperm into a female's cervix or uterine cavity for the purpose of achieving a pregnancy through in vivo fertilization by means other than sexual intercourse. resulting from artificial insemination is no different from a pregnancy achieved by sexual intercourse. In all. ceeding 10 million for IUI, no further improvement in conception rates was but intercourse on the day of hCG administration might cause con-.

ceeding 10 million for IUI, no further improvement in conception rates was but intercourse on the day of hCG administration might cause con-. Artificial insemination (AI) is the deliberate introduction of sperm into a female's cervix or uterine cavity for the purpose of achieving a pregnancy through in vivo fertilization by means other than sexual intercourse. resulting from artificial insemination is no different from a pregnancy achieved by sexual intercourse. In all. Timed intercourse after intrauterine insemination for treatment of infertility. CONCLUSIONS: In IUI with low number of motile sperm inseminated, timed.






To evaluate the effect of intrauterine insemination IUI on sexual functioning, quality of life and psychological well-being. One hundred and thirty four infertile women going to IUI treatment as study group and women who do not report any infertility complaint attending to gynecology clinic for routine control as control group were enrolled.

Demographic data of the patients were collected. This means a lower sexual function for patients going to IUI. There were also statistically significant differences according to subscales of FSFI scores for sexual desire, arousal and satisfaction.

According to SF scores, there were statistically significant differences between the groups for four subscales: Role physical,bodily pain,general health and vitality. Infertility is a disease characterized by the failure to establish a clinical pregnancy after 12 months of regular, unprotected sexual intercourse.

Some infertile couples have some psychological difficulties, including; lack of marital satisfaction, impairment of relationships, lack of sexual satisfaction, forced timing of intercourse, loss of confidence in relation to sex, decreased libido and negative emotional sex. Some of them reported higher prevalence of sexual dysfunction in infertile females, 67 whereas insemination others revealed no significant difference between fertile and infertile females.

Infertility may also have a negative effect on the Quality Of Life QOL for the woman and maybe a cause of developing depression. Depression may be another problem which a female may experience if she has infertility.

In the literature, there are some articles concluding that infertility may sex depression and some articles deny such a relation. To our knowladge, there is no study invastigating the sexual problems and quality of life of females who are going to IUI treatment.

The aim and our study was to evaluate the effect of starting an IUI cycle on sexual functioning, quality of life and psychological well-being for sex in comparison with a group of presumed fertile women. Women aged between years attending to infertility clinic of Suleymaniye Maternity Research and Training Hospital for IUI treatment were included in this prospective study as study group Group 1 between January and February Women attending the gynecology clinic for general control without any complaints were taken as control group Group 2.

A total of patients study group and control group entered the study. One hundred forty two patients were invited to answer the questionnaries for the study group but six of them refused to and the FSFI questionnarie and two of them answerred the questionnaries but there were missing data; so these eight women were excluded from the study. Non-pregnant and non-lactating, in a sexual relationship during the last 4 weeks were prospectively included in the study.

Women with insemination psychiatric diseases, using antipsychotic drugs, genitourinary infection, genital tract abnormality, physical disabilities, and having chronic medical conditions associated with sexual dysfunction were excluded.

Females with partners that had erectile or ejaculation disturbances associated with sexual dysfunction were also excluded. All participants from the control group had at least one living child. None of the patients in the control group did not have any and while attending to hospital. They were just attending to gynaecology clinic for routine control. Infertile women included all those who were experiencing primary or secondary infertility.

Participants who had never been able to conceive were diagnosed as primary infertility, whereas those with a previous history of pregnancy were diagnosed as secondary infertility.

Ethical committee approval was taken before starting the data collection. All participants gave informed consent after which demographic data and reproductive history sex the patients were collected. Patients were asked to complete three self-administered questionnaires. Study group patients filled the questionnaries for the month just before starting to use the drugs related the IUI practice.

All patients underwent stimulated IUI cycles, but administration of hormonal treatment is not a confounding variable because all our sex answered the questionnaries before starting any treatment. For the control group, patients were requested to answer the questionnaries after their physical examination evaluating the previous month.

These eight subscales are scored from 0 to where indicates the sex level of health status. The Female Sexual Functioning Index FSFI is a item multidimensional insemination measuring six domains including sexual desire, arousal both subjective and physiologicallubrication, orgasm, satisfaction, and pain.

Each domain was scored on a scale of 0 to 6, with higher scores indicating better sexual function for each domain. It consisted of 21 questions on particular aspects of depression related symptoms.

Total score ranged from 0 to Mean, standard deviation, median, minimum, maximum value frequency and percentage were used for descriptive statistics.

The distribution of variables was checked with kolmogorov-simirnov test. Mann-whitney U test was used for the comparison of quantitative data. Chi-Square test was used for the comparison of the qualitative data.

SPSS The mean age was Also there and not a sex significant difference for BMI rates between the groups Mean duration of infertility was All patients in the control group had at least one child. Demographic characteristics of the patients are shown in Table-I.

Forty two out of patients This means a lower sexual function in infertile women. There were also statistically significant differences between groups according to subscale of FSFI scores for sexual desire 3. There were no statistically significant differences for other subscales of FSFI between groups.

Twenty out of There were no statistically significant differences for other subscales of SF between the groups. Scores for all patients and for all questionnaries are shown in Table-II. Sexual function is one of the important components of health and overall quality of life.

It is associated with feelings of loss of control, diminished self-esteem, anxiety and depression. As we found lower FSFI scores insemination infertile patients, similar to us Oddens at al and Drosdzol et al reported lower sexual life satisfaction for infertile patients when compared with healthy controls. We found significant difference between groups for sexual desire, arousal and satisfaction subgroups of FSFI.

Howbeit insemination in satisfaction subgroup is revealed to be common in Turkish women. Prior studies have indicated that infertile women report more depressive symptoms than controls.

In a study of infertile women and 39 healthy controls, women who had a duration of infertility between two to three years and a higher prevelance of depression compared with the control group.

The relationship between female infertility and depression remains somewhat unclear. As a result of this acceptance, although infertility affects sexual function and some of SF 36 scores, its effect on BDI scores is limited. Drosdzol et al and Souter et al reported lower QoL among infertile women but different from us Souter et al reported lower scores in all SF categories as we found lower scores for role physical, bodily pain, general health and vitality subgroups.

This correlation was only on physical function subdomain. Different from Western cultures where marriages are thought to be result of love, for such a population like ours, marriage is based on family constitution. Therefore low marital satisfaction especially among women may be a common problem.

Higher BDI scores, lower quality of life and higher frequencies of sexual problems may be more common for both our infertiile and also fertile group of patients. The sample size might sex larger to generalize the findings. The etiology of infertility in these couples was not assessed.

Our SF 36 analyzes also shows similar insemination that generally physical component of the questionnarie is negatively effected for infertile patients role physical, bodily pain and general health. Only vitality subgroup of SF 36 questionnarie which is related insemination mental component summary is worser in infetile patients. The second finding of our study is that there are no group differences in symptoms of depression, is a good news that adds to existing evidence that, although infertility is distressing, and is no more common among infertile than fertile women.

Infertile patients may perceive IVF treatment as the last chance of having a baby and a more stressful process but our study demonstrated that planning an IUI treatment also have unfavourable effects. We investigated the effect of going to an IUI treatment on sexual functioning and quality of life on infertile women and found lower FSFI and SF 36 scores but we did not find a significant negative effect on BDI scores.

Worse sexual functioning and quality of life probably indicates that anticipating intrauterine insemination treatment is a stressful life event. We may help them by normalizing their feelings and by explaining that it is common to feel less interested in insemination leading up to treatment and make sure that they may seek help from a counsellor if this persists.

ESG: Conceived, designed and editing of manuscript. Disclosure statement: The authors report no conflicts of interest. National Center for Biotechnology InformationU. Pak J Med Sci. Olcay Seval 2 Olcay Seval, M. Fatma Ferda Verit 4 Prof. Author information Article notes Copyright and License information Disclaimer. Correspondence: Dr. Emre Sinan Gungor, M. E-mail: moc.

Abstract Objectives: To evaluate the effect of intrauterine insemination IUI on sexual functioning, quality of life and psychological well-being. Methods: One hundred and thirty four infertile women going to IUI treatment as study group and women who do not report any infertility complaint attending to gynecology clinic for routine control as and group were enrolled.

Keywords: Intrauterine insemination, Infertile women, Sexual function, Quality of life, depression. Table-I Demographic characteristics of the patients. Standard Deviation. Open in a separate window. Median Beck Depression Score Limitations of the study The sample size might be larger to generalize the findings. OS, GI: Did data collection and manuscript writing. FFV: Did review and final approval of manuscript. Hum Reprod. Prevalence of and in the United States as estimated by the current duration approach and a traditional constructed approach.

There were no statistically significant differences for other subscales of FSFI between groups. Twenty out of There were no statistically significant differences for other subscales of SF between the groups. Scores for all patients and for all questionnaries are shown in Table-II. Sexual function is one of the important components of health and overall quality of life.

It is associated with feelings of loss of control, diminished self-esteem, anxiety and depression. As we found lower FSFI scores for infertile patients, similar to us Oddens at al and Drosdzol et al reported lower sexual life satisfaction for infertile patients when compared with healthy controls. We found significant difference between groups for sexual desire, arousal and satisfaction subgroups of FSFI. Howbeit problems in satisfaction subgroup is revealed to be common in Turkish women.

Prior studies have indicated that infertile women report more depressive symptoms than controls. In a study of infertile women and 39 healthy controls, women who had a duration of infertility between two to three years reported a higher prevelance of depression compared with the control group.

The relationship between female infertility and depression remains somewhat unclear. As a result of this acceptance, although infertility affects sexual function and some of SF 36 scores, its effect on BDI scores is limited. Drosdzol et al and Souter et al reported lower QoL among infertile women but different from us Souter et al reported lower scores in all SF categories as we found lower scores for role physical, bodily pain, general health and vitality subgroups.

This correlation was only on physical function subdomain. Different from Western cultures where marriages are thought to be result of love, for such a population like ours, marriage is based on family constitution. Therefore low marital satisfaction especially among women may be a common problem. Higher BDI scores, lower quality of life and higher frequencies of sexual problems may be more common for both our infertiile and also fertile group of patients.

The sample size might be larger to generalize the findings. The etiology of infertility in these couples was not assessed. Our SF 36 analyzes also shows similar results that generally physical component of the questionnarie is negatively effected for infertile patients role physical, bodily pain and general health.

Only vitality subgroup of SF 36 questionnarie which is related with mental component summary is worser in infetile patients. The second finding of our study is that there are no group differences in symptoms of depression, is a good news that adds to existing evidence that, although infertility is distressing, psychopathology is no more common among infertile than fertile women.

Infertile patients may perceive IVF treatment as the last chance of having a baby and a more stressful process but our study demonstrated that planning an IUI treatment also have unfavourable effects. We investigated the effect of going to an IUI treatment on sexual functioning and quality of life on infertile women and found lower FSFI and SF 36 scores but we did not find a significant negative effect on BDI scores.

Worse sexual functioning and quality of life probably indicates that anticipating intrauterine insemination treatment is a stressful life event. We may help them by normalizing their feelings and by explaining that it is common to feel less interested in sex leading up to treatment and make sure that they may seek help from a counsellor if this persists.

ESG: Conceived, designed and editing of manuscript. Disclosure statement: The authors report no conflicts of interest. National Center for Biotechnology Information , U. Pak J Med Sci. Olcay Seval 2 Olcay Seval, M. Fatma Ferda Verit 4 Prof. Author information Article notes Copyright and License information Disclaimer.

Correspondence: Dr. Emre Sinan Gungor, M. E-mail: moc. Abstract Objectives: To evaluate the effect of intrauterine insemination IUI on sexual functioning, quality of life and psychological well-being. Methods: One hundred and thirty four infertile women going to IUI treatment as study group and women who do not report any infertility complaint attending to gynecology clinic for routine control as control group were enrolled.

Keywords: Intrauterine insemination, Infertile women, Sexual function, Quality of life, depression. Table-I Demographic characteristics of the patients. Standard Deviation. Open in a separate window.

Median Beck Depression Score Limitations of the study The sample size might be larger to generalize the findings. OS, GI: Did data collection and manuscript writing. FFV: Did review and final approval of manuscript. Hum Reprod. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. J Clin Diag Res.

Stress and distress in infertility among women. Cousineau T, Domar A. Psychological impact of infertility. Is infertility a risk factor for female sexual dysfunction? A case-control study. Prevalence and risk factors of the female sexual dysfunction in a sample of infertile Iranian women. Arch Gynecol Obstet. Dyspareunia and sexual dysfunction in women seeking fertility treatment. Effects of infertility and infertility duration on female sexual functions.

Social Sci Med. Psychosocial experiences in women facing fertility problems-A comparative survey. Moderate or severe depression is uncommon in women seeking infertility therapy according to the beck depression inventory. Clin Exp Obstet Gynecol. Anxiety and depression symptoms among sub-fertile women, women pregnant after infertility treatment, and naturally pregnant women.

Eur Psychiatry. Adaptation, reliability and validity testing of a Persian version of the Health Assessment Questionnaire-Disability Index in Iranian patients with rheumatoid arthritis. J Bodyw Mov Ther. During I. But IUI is much simpler. A typical IUI cycle begins at the start of your period and ends when you take a blood pregnancy test, about two weeks after your IUI. Your doctors will often perform a transvaginal ultrasound to examine your uterine lining and your ovarian follicles the small, fluid-filled sacs in your ovaries that typically contain one immature, microscopic egg.

During the weeks before ovulation, your doctor will perform additional ultrasounds to make sure that your uterine lining is thickening and your follicles are growing. When at least one mature follicle on the ultrasound measures over 20 millimeters, ovulation is likely to happen soon. At this point, your doctor might instruct you to take an hCG trigger shot which induces ovulation about 36 hours after the injection and will schedule your IUI. Or, your doctor might tell you to continue measuring the level of luteinizing hormone which peaks 24 to 48 hours before ovulation in your urine with an at-home test.

When the test indicates that your LH levels have peaked, the IUI is typically performed the following day. If you are using sperm from a male partner, he will come to the clinic on the day of your IUI to deposit a sample, and the fertility clinic will prepare it for insemination.

This process involves washing it to remove unwanted substances like non-motile sperm, white blood cells and prostaglandins hormone-like chemicals that can cause painful cramping when deposited into the uterus.

During the IUI, your doctor will insert a speculum into your vagina and thread a thin, flexible catheter through your cervix to deposit sperm into your uterus. The entire process usually takes about 5 minutes. Your doctor will likely advise you to lie down for about 10 minutes after the procedure to prevent you from feeling lightheaded or dizzy.

About a week later, many fertility clinics will check your progesterone levels with a blood test to determine whether you actually ovulated around the time of the procedure.

It can be tempting to read into every symptom you experience. Only the blood test will offer official confirmation. In the past, women undergoing IUI were sometimes prescribed gonadotropin injections that would stimulate the ovaries to release multiple follicles, but studies have shown that there is a higher likelihood of multiples with gonadotropins than there is with two of the more commonly used ovulation-inducing drugs, clomiphene citrate or letrozole.

Clomiphene Clomid or Serophene , is currently the only oral drug that is approved to induce ovulation. It prompts egg growth by stimulating follicles in the ovaries. In fact, some studies have suggested that it is more effective than clomiphene in women who have polycystic ovary syndrome, or PCOS. As a result, letrozole is widely used for ovulation induction.

Another commonly prescribed medication is the human chorionic gonadotropin shot, also referred to as a hCG trigger shot Ovidrel.

For many women undergoing IUI, these drugs can be a game changer. The hCG trigger shot, for instance, can cause ovarian hyperstimulation syndrome, a condition that can result in painful, swollen ovaries.

Your doctor can help you weigh the potential benefits of medication against the possible risks. Martha Noel, M. Occasionally, the catheter can create some discomfort as well, especially if you have cervical stenosis and the passageway through the cervix is narrow, or if the tilt of your uterus makes insertion more challenging. Noel said. After an IUI, you can do nearly everything you used to do with two exceptions.

Paula C. Brady, M. Gargiulo, M. But we do know that while IUI is less invasive and less expensive than I.